Authors:
Sharrack, B
Hughes, RAC
Morris, RW
Soudain, S
Wade-Jones, O
Barnes, D
Brown, P
Britton, T
Francis, DA
Perkin, GD
Rudge, P
Swash, M
Katifi, HA
Farmer, S
Frankel, JP
Citation: B. Sharrack et al., The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis, J NEUR SCI, 173(1), 2000, pp. 73-77
Authors:
Banati, RB
Newcombe, J
Gunn, RN
Cagnin, A
Turkheimer, F
Heppner, F
Price, G
Wegner, F
Giovannoni, G
Miller, DH
Perkin, GD
Smith, T
Hewson, AK
Bydder, G
Kreutzberg, GW
Jones, T
Cuzner, ML
Myers, R
Citation: Rb. Banati et al., The peripheral benzodiazepine binding site in the brain in multiple sclerosis - Quantitative in vivo imaging of microglia as a measure of disease activity, BRAIN, 123, 2000, pp. 2321-2337
Authors:
Steiner, TJ
Dellaportas, CI
Findley, LJ
Gross, M
Gibberd, FB
Perkin, GD
Park, DM
Abbott, R
Citation: Tj. Steiner et al., Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin, EPILEPSIA, 40(5), 1999, pp. 601-607